AUSHON.COM

Aushon BioSystems

Aushon Ciraplex® ULTRA Ultrasensitive Assays combine the power of multiplexing and ultrasensitivity with femtogram/ml (fg/ml) levels of detection. The Cira™ immunoassay platform was specifically designed by a team of Aushon engineers and biologists to offer accurate multiplex biomarker analysis with simplicity and savings in mind. The Cira™ platform combines the accuracy and precision of ELISA, the sensitivity of chemiluminescence, and the throughput and affordability of multiplexing.

http://www.aushon.com/

OVERVIEW OF aushon.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR AUSHON.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 5 reviews

5 star

0

4 star

5

3 star

0

2 star

0

1 star

0

Hey there! Start your review of aushon.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.8 seconds

CONTACTS AT AUSHON.COM

Aushon BioSystems, Inc.

43 M●●●●g Rd

Bil●●●ica , MA, 01821

US

978-●●●●6400

no●●●●●●●●●●●●@worldnic.com

View this contact

Aushon BioSystems, Inc.

Aushon BioSystems, Inc.

43 M●●●●g Rd

Bil●●●ica , MA, 01821

US

978-●●●●6400

sc●●●@aushon.com

View this contact

Aushon BioSystems, Inc.

Aushon BioSystems, Inc.

43 M●●●●g Rd

Bil●●●ica , MA, 01821

US

978-●●●●6400

sc●●●@aushon.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2003 June 01
UPDATED: 2014 February 14
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

22

YEARS
4

MONTHS
26

DAYS

NAME SERVERS

1: dns1.anhosting.com
2: dns2.anhosting.com

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

15

SSL

EXTERNAL LINKS

85

SITE IP

174.127.109.220

LOAD TIME

0.766 sec

SCORE

6.2

PAGE TITLE

Aushon BioSystems | aushon.com Reviews

<META> DESCRIPTION

Aushon Ciraplex® ULTRA Ultrasensitive Assays combine the power of multiplexing and ultrasensitivity with femtogram/ml (fg/ml) levels of detection. The Cira™ immunoassay platform was specifically designed by a team of Aushon engineers and biologists to offer accurate multiplex biomarker analysis with simplicity and savings in mind. The Cira™ platform combines the accuracy and precision of ELISA, the sensitivity of chemiluminescence, and the throughput and affordability of multiplexing.

<META> KEYWORDS

1 immunoassay

2 multiplex immunoassay

3 multiplex immuno assay

4 multiplex imuno assay

5 384 microtiter

6 384 well

7 microtiter

8 96 half volume

9 imager

10 elisa

CONTENT

Page content here

KEYWORDS ON PAGE

products and services,cro partners,resource center,news,ultrasensitivity,recent aushon news,comparison of human,aushon biosystems,43 manning rd,info@aushon com

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Aushon BioSystems | aushon.com Reviews

https://aushon.com

Aushon Ciraplex® ULTRA Ultrasensitive Assays combine the power of multiplexing and ultrasensitivity with femtogram/ml (fg/ml) levels of detection. The Cira™ immunoassay platform was specifically designed by a team of Aushon engineers and biologists to offer accurate multiplex biomarker analysis with simplicity and savings in mind. The Cira™ platform combines the accuracy and precision of ELISA, the sensitivity of chemiluminescence, and the throughput and affordability of multiplexing.

INTERNAL PAGES

aushon.com

1

Aushon BioSystems: Aushon Assay Services

http://www.aushon.com/Custom-Arrays-and-Assay-Development.php

Cirascan™ Imaging and Cirasoft™ Analysis. Custom Arrays vs. Standard Kits. Analyzing samples for a panel of cytokines and specific biomarkers offers a more complete picture of disease progression, performance of potential drug candidates, and effectiveness of treatment than traditional single-analyte ELISA methods. We offer chemiluminescent Multiplex Assay Kits for popular combinations of cytokines and chemokines, but multiplex analysis is most powerful when it can be customized. Potential Biomarkers for...

2

Aushon Biosystems: Multiplexed Immunoassay Diagnostics Webinar

http://www.aushon.com/Webinars/Diagnostic-Webinar.php

Multiplexed Immunoassay Diagnostics: Forward-Phase and Reverse-Phase Applications. Multiplexed assays for simultaneously detecting several biomarkers in a single sample are becoming popular in clinical diagnostic research. An advantage of multiplexing in diagnostics is that patterns of several biomarkers have better predictive value compared to detection of a single analyte using ELISAs. This web seminar presents, using an interactive format, the multiplexing platforms available for immunoassay d...

3

Aushon BioSystems: News Releases

http://www.aushon.com/release.php?r=20140514

Aushon Expands Technology Portfolio for Biomarker Analysis. Three key new patents are issued to Aushon for its Multiplex Platform. Billerica, Mass. — May 14, 2014. 8212; Aushon BioSystems. A leading provider of products and services for multiplex quantitative detection of protein biomarkers, today announced that it has continued to build its patent portfolio with the issuance of three new patents. Http:/ www.aushon.com. Billerica, MA 01821.

4

Aushon BioSystems: Products & Services

http://www.aushon.com/Products-and-Services.php

Cirascan™ Imaging and Cirasoft™ Analysis. Cira™ Immunoassay Platform Overview. The Cira immunoassay platform revolutionizes protein biomarker research combining ELISA’s sensitivity and reproducibility with all the advantages of multiplexing. Only Cira™ delivers on the promise of multiplexing’s throughput and affordability without compromising the sensitivity and consistency of singleplex ELISA. The Cira™ immunoassay platform consists of the following products and services:. Is the precision printing tech...

5

Aushon BioSystems: Products & Services

http://www.aushon.com/2470-Arrayer.php

CiraScan™ Imaging and Analysis System. Learn from the Experts. Listen and watch as a distinguished panel of scientific innovators and recognized thought leaders present their research using the RPA platform in a variety of applications. Unmatched sample flexibilty (DNA to Cell Lysates). Capable of printing on most any substrate. High density printing with unequaled accuracy. Fully enclosed printing platform. Unmatched protein array functionality. Our proprietary deposition technology reliably produces ce...

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

aushon.info

Aushon BioSystems: News Releases

http://www.aushon.info/release.php?r=20140603

Researchers from the UK Present Biomarker Test Results from Phase II Clinical Trial for Treatment of Patients with Advanced Biliary Tract Cancer. Billerica, Mass. — June 3, 2014. 8212; Aushon BioSystems. A leading provider of multiplex immunoassay products and services, today announced that results from a clinical trial which includes biomarker data using Aushon’s multiplex Cira platform was presented at ASCO’s Annual Meeting in Chicago this week by researchers from the U.K. Http:/ www.aushon.com.

aushon.us

Aushon BioSystems: News Releases

http://aushon.us/release.php?r=20140514

Aushon Expands Technology Portfolio for Biomarker Analysis. Three key new patents are issued to Aushon for its Multiplex Platform. Billerica, Mass. — May 14, 2014. 8212; Aushon BioSystems. A leading provider of products and services for multiplex quantitative detection of protein biomarkers, today announced that it has continued to build its patent portfolio with the issuance of three new patents. Http:/ www.aushon.com. Billerica, MA 01821.

aushon.us

Aushon BioSystems: News Releases

http://aushon.us/release.php?r=20140603

Researchers from the UK Present Biomarker Test Results from Phase II Clinical Trial for Treatment of Patients with Advanced Biliary Tract Cancer. Billerica, Mass. — June 3, 2014. 8212; Aushon BioSystems. A leading provider of multiplex immunoassay products and services, today announced that results from a clinical trial which includes biomarker data using Aushon’s multiplex Cira platform was presented at ASCO’s Annual Meeting in Chicago this week by researchers from the U.K. Http:/ www.aushon.com.

aushon.biz

Aushon BioSystems: News Releases

http://www.aushon.biz/release.php?r=20140514

Aushon Expands Technology Portfolio for Biomarker Analysis. Three key new patents are issued to Aushon for its Multiplex Platform. Billerica, Mass. — May 14, 2014. 8212; Aushon BioSystems. A leading provider of products and services for multiplex quantitative detection of protein biomarkers, today announced that it has continued to build its patent portfolio with the issuance of three new patents. Http:/ www.aushon.com. Billerica, MA 01821.

nbvp.northbridge.com

Portfolio | North Bridge

http://nbvp.northbridge.com/portfolio-all/all

cira-plex.us

Aushon BioSystems: News Releases

http://www.cira-plex.us/release.php?r=20140603

Researchers from the UK Present Biomarker Test Results from Phase II Clinical Trial for Treatment of Patients with Advanced Biliary Tract Cancer. Billerica, Mass. — June 3, 2014. 8212; Aushon BioSystems. A leading provider of multiplex immunoassay products and services, today announced that results from a clinical trial which includes biomarker data using Aushon’s multiplex Cira platform was presented at ASCO’s Annual Meeting in Chicago this week by researchers from the U.K. Http:/ www.aushon.com.

cirascan.com

Aushon BioSystems: News Releases

http://www.cirascan.com/release.php?r=20140514

Aushon Expands Technology Portfolio for Biomarker Analysis. Three key new patents are issued to Aushon for its Multiplex Platform. Billerica, Mass. — May 14, 2014. 8212; Aushon BioSystems. A leading provider of products and services for multiplex quantitative detection of protein biomarkers, today announced that it has continued to build its patent portfolio with the issuance of three new patents. Http:/ www.aushon.com. Billerica, MA 01821.

ciraplex.net

Aushon BioSystems: News Releases

http://www.ciraplex.net/release.php?r=20140603

Researchers from the UK Present Biomarker Test Results from Phase II Clinical Trial for Treatment of Patients with Advanced Biliary Tract Cancer. Billerica, Mass. — June 3, 2014. 8212; Aushon BioSystems. A leading provider of multiplex immunoassay products and services, today announced that results from a clinical trial which includes biomarker data using Aushon’s multiplex Cira platform was presented at ASCO’s Annual Meeting in Chicago this week by researchers from the U.K. Http:/ www.aushon.com.

UPGRADE TO PREMIUM TO VIEW 77 MORE

TOTAL LINKS TO THIS WEBSITE

85

OTHER SITES

aushomes.com

aushomes.com - Premium Domain Names For Sale - NameStore.com

This Domain Name Is For Sale At NameStore.com. Premium Domain Names For Sale - NameStore.com. This Domain Name Is For Sale At NameStore.com.

aushomes.com.au

AusHomes Building Better Homes

Call us 07 3809 5999. At a price you can see and afford. See the Aus Homes. Call 07 3809 5999. News & Media. ACN: 075 853 726 QBCC No.: 77058. All content Aushomes Pty Ltd.

aushomesearch.com

Austin Texas home search. MLS listings

Austin Texas home search. MLS listings.

aushomesforsale.com

Australian Homes For Sale by Owner

1300 24 22 69. Price (High - Low). Price (Low - High). Suburb (A - Z). Suburb (Z - A). Page 1 of 20. Sorrento, WA 6020. Green Titled flat level Block 600 square metres. Possible ocean glimpses from second floor 500 metres to beach, 200 metres. North Coogee, WA 6163. Offers over $1,000,000. Looking for a low maintenance property situated in a raised elevated position of this stunning coastal area of Port Coogee. Contemporary home with Ocean Views. Ellesmere, QLD 4610. Manoora, SA 5414. Granville, QLD 4650.

aushon.biz

Aushon BioSystems

9/26/17 Aushon BioSystems and ABL, Inc. Announce Adoption of the Cira™ Platform for Multiplex and Ultrasensitive Biomarker Testing . 7/11/17 Strategic Collaboration Between Aushon BioSystems and RDL Reference Laboratory Announced for Advancing Precision Medicine. 5/17/17 Stanley N. Lapidus Joins Aushon’s Board of Directors. Annual Biomarker and Diagnostic World Congress 2017 in Philadelphia. 5/17/16 Aushon sponsors the 12th Annual Biomarker and Diagnostics World Congress 2016. 9/8/15 Bruns Grayson Joins ...

aushon.com

Aushon BioSystems

9/26/17 Aushon BioSystems and ABL, Inc. Announce Adoption of the Cira™ Platform for Multiplex and Ultrasensitive Biomarker Testing . 7/11/17 Strategic Collaboration Between Aushon BioSystems and RDL Reference Laboratory Announced for Advancing Precision Medicine. 5/17/17 Stanley N. Lapidus Joins Aushon’s Board of Directors. Annual Biomarker and Diagnostic World Congress 2017 in Philadelphia. 5/17/16 Aushon sponsors the 12th Annual Biomarker and Diagnostics World Congress 2016. 9/8/15 Bruns Grayson Joins ...

aushon.info

Aushon BioSystems

9/26/17 Aushon BioSystems and ABL, Inc. Announce Adoption of the Cira™ Platform for Multiplex and Ultrasensitive Biomarker Testing . 7/11/17 Strategic Collaboration Between Aushon BioSystems and RDL Reference Laboratory Announced for Advancing Precision Medicine. 5/17/17 Stanley N. Lapidus Joins Aushon’s Board of Directors. Annual Biomarker and Diagnostic World Congress 2017 in Philadelphia. 5/17/16 Aushon sponsors the 12th Annual Biomarker and Diagnostics World Congress 2016. 9/8/15 Bruns Grayson Joins ...

aushon.net

AushonJapan

Uhttp:/ www.aushon.net/ v @Body Maintenance @ Í. Uhttp:/ www.hothands.jp/ v @HOT HANDS @ É Ï X Æ È è Ü µ B. 5 b ã É uhttp:/ www.hothands.jp/ v. 5 b È à É Ú µ È ê Í A http:/ www.hothands.jp/.

aushon.org

Aushon BioSystems

9/26/17 Aushon BioSystems and ABL, Inc. Announce Adoption of the Cira™ Platform for Multiplex and Ultrasensitive Biomarker Testing . 7/11/17 Strategic Collaboration Between Aushon BioSystems and RDL Reference Laboratory Announced for Advancing Precision Medicine. 5/17/17 Stanley N. Lapidus Joins Aushon’s Board of Directors. Annual Biomarker and Diagnostic World Congress 2017 in Philadelphia. 5/17/16 Aushon sponsors the 12th Annual Biomarker and Diagnostics World Congress 2016. 9/8/15 Bruns Grayson Joins ...

aushon.us

Aushon Biosystems: Microarrayer Instrumentation l Proteomic Biomarker Kits

6/3/14 Researchers from the UK Present Biomarker Test Results from Phase II Clinical Trial for Treatment of Patients with Advanced Biliary Tract Cancer. 5/14/14 Aushon Expands Technology Portfolio for Biomarker Analysis - Three key new patents are issued to Aushon for its Multiplex Platform. 6/3/14 Researchers from the UK Present Biomarker Test Results from Phase II Clinical Trial for Treatment of Patients with Advanced Biliary Tract Cancer. Introducing the Cira™ immunoassay platform. Billerica, MA 01821.

aushonbiosystems.com

Aushon BioSystems

9/26/17 Aushon BioSystems and ABL, Inc. Announce Adoption of the Cira™ Platform for Multiplex and Ultrasensitive Biomarker Testing . 7/11/17 Strategic Collaboration Between Aushon BioSystems and RDL Reference Laboratory Announced for Advancing Precision Medicine. 5/17/17 Stanley N. Lapidus Joins Aushon’s Board of Directors. Annual Biomarker and Diagnostic World Congress 2017 in Philadelphia. 5/17/16 Aushon sponsors the 12th Annual Biomarker and Diagnostics World Congress 2016. 9/8/15 Bruns Grayson Joins ...